Authors: Hajitou, A Sounni, NE Devy, L Grignet-Debrus, C Lewalle, JM Li, H Deroanne, CF Lu, H Colige, A Nusgens, BV Frankenne, F Maron, A Yeh, P Perricaudet, M Chang, YW Soria, C Calberg-Bacq, CM Foidart, JM Noel, A

Citation: A. Hajitou et al., Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: Effect on in vivo mammary tumor growth and angiogenesis, CANCER RES, 61(8), 2001, pp. 3450-3457

Authors: Noel, A Boulay, A Kebers, F Kannan, R Hajitou, A Calberg-Bacq, CM Basset, P Rio, MC Foidart, JM

Citation: A. Noel et al., Demonstration in vivo that stromelysin-3 functions through its proteolyticactivity, ONCOGENE, 19(12), 2000, pp. 1605-1612

Authors: Grignet-Debrus, C Cool, V Baudson, N Degreve, B Balzarini, J De Leval, L Debrus, S Velu, T Calberg-Bacq, CM

Citation: C. Grignet-debrus et al., Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2 '-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressingeither the Varicella zoster or the Herpes simplex virus thymidine kinase, CANC GENE T, 7(2), 2000, pp. 215-223

Authors: Grignet-Debrus, C Cool, V Baudson, N Velu, T Calberg-Bacq, CM

Citation: C. Grignet-debrus et al., The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella tester and Herpes simplex viral thymidine kinases in suicide gene therapy, CANC GENE T, 7(11), 2000, pp. 1456-1468

Authors: Hajitou, A Deroanne, C Noel, A Collette, J Nusgens, B Foidart, JM Calberg-Bacq, CM

Citation: A. Hajitou et al., Progression in MCF-7 breast cancer cell tumorigenicity: compared effect ofFGF-3 and FGF-4, BREAST CANC, 60(1), 2000, pp. 15-28